# BranchOut Food Inc.: overview

BOF · Nasdaq · CIK 1962481 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bof.md) · [Financials](/companies/bof/financials.md) · [Filings](/companies/bof/filings.md) · [Insiders](/companies/bof/insiders.md)

Latest reported revenue: [$4.5m](/filings/0001493152-26-037732.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 13, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001493152-26-037732).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [2,181](/filings/0001493152-25-021655.md) | [1,423 d](/filings/0001493152-26-014040.md) | [3,171](/filings/0001493152-26-023046.md) | [3,275](/filings/0001493152-26-037732.md) | [3,220](/filings/0001493152-25-021655.md) | [4,011 d](/filings/0001493152-26-014040.md) | [2,607](/filings/0001493152-26-023046.md) | [4,458](/filings/0001493152-26-037732.md) |
| Gross margin | % | [15.4%](/filings/0001493152-25-021655.md) | [0.9% d](/filings/0001493152-26-014040.md) | [16.7%](/filings/0001493152-26-023046.md) | [17.8%](/filings/0001493152-26-037732.md) | [17.7%](/filings/0001493152-25-021655.md) | [7.6% d](/filings/0001493152-26-014040.md) | [15.4%](/filings/0001493152-26-023046.md) | [2.2%](/filings/0001493152-26-037732.md) |
| Operating margin | % | [(41.4%)](/filings/0001493152-25-021655.md) | [(80.7%) d](/filings/0001493152-26-014040.md) | [(20.3%)](/filings/0001493152-26-023046.md) | [(40.0%)](/filings/0001493152-26-037732.md) | [(44.3%)](/filings/0001493152-25-021655.md) | [(47.6%) d](/filings/0001493152-26-014040.md) | [(62.1%)](/filings/0001493152-26-023046.md) | [(57.5%)](/filings/0001493152-26-037732.md) |
| Net margin | % | [(58.3%)](/filings/0001493152-25-021655.md) | [(104.5%) d](/filings/0001493152-26-014040.md) | [(29.0%)](/filings/0001493152-26-023046.md) | [(49.0%)](/filings/0001493152-26-037732.md) | [(48.8%)](/filings/0001493152-25-021655.md) | [(50.6%) d](/filings/0001493152-26-014040.md) | [(68.8%)](/filings/0001493152-26-023046.md) | [(61.0%)](/filings/0001493152-26-037732.md) |
| Diluted EPS | $ per share | [(0.19)](/filings/0001493152-25-021655.md) | not reported | [(0.11)](/filings/0001493152-26-023046.md) | [(0.17)](/filings/0001493152-26-037732.md) | [(0.14)](/filings/0001493152-25-021655.md) | not reported | [(0.12)](/filings/0001493152-26-023046.md) | [(0.18)](/filings/0001493152-26-037732.md) |
| Free cash flow | $k | [(3,446) d](/filings/0001493152-25-021655.md) | [(2,328) d](/filings/0001493152-26-014040.md) | [(2,315)](/filings/0001493152-26-023046.md) | [(2,140) d](/filings/0001493152-26-037732.md) | [(1,183) d](/filings/0001493152-25-021655.md) | [(2,109) d](/filings/0001493152-26-014040.md) | [(2,611)](/filings/0001493152-26-023046.md) | [(2,993) d](/filings/0001493152-26-037732.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: |
| Revenue | $m | [0.8](/filings/0001493152-24-012492.md) | [2.8](/filings/0001641172-25-004712.md) | [6.4](/filings/0001493152-26-014040.md) | [13.7](/filings/0001493152-26-014040.md) |
| Gross margin | % | [(22.7%)](/filings/0001493152-24-012492.md) | [(3.4%)](/filings/0001641172-25-004712.md) | [12.2%](/filings/0001493152-26-014040.md) | [14.8%](/filings/0001493152-26-014040.md) |
| Operating margin | % | [(319.9%)](/filings/0001493152-24-012492.md) | [(123.9%)](/filings/0001641172-25-004712.md) | [(60.6%)](/filings/0001493152-26-014040.md) | [(39.1%)](/filings/0001493152-26-014040.md) |
| Net margin | % | [(617.3%)](/filings/0001493152-24-012492.md) | [(138.9%)](/filings/0001641172-25-004712.md) | [(73.8%)](/filings/0001493152-26-014040.md) | [(44.6%)](/filings/0001493152-26-014040.md) |
| Diluted EPS | $ per share | [(3.87)](/filings/0001493152-24-012492.md) | [(1.44)](/filings/0001641172-25-004712.md) | [(0.83)](/filings/0001493152-26-014040.md) | [(0.57)](/filings/0001493152-26-014040.md) |
| Free cash flow | $m | [(2.5)](/filings/0001493152-24-012492.md) | [(3.6)](/filings/0001641172-25-004712.md) | [(7.7)](/filings/0001493152-26-014040.md) | [(7.7)](/filings/0001493152-26-014040.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/bof/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [KENNEDY CAPITAL MANAGEMENT LLC](/funds/884589.md) | 2026-06-30 | $5.5m | 1,201,458 |  | New +1,201,458 |
| [BARD ASSOCIATES INC](/funds/1105907.md) | 2026-06-30 | $4.7m | 1,030,329 |  | Reduced −4,271 |
| [STIFEL FINANCIAL CORP](/funds/720672.md) | 2026-06-30 | $2.8m | 616,300 |  | Added +62,031 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $1.8m | 398,019 |  | Added +25,803 |
| [SEI INVESTMENTS CO](/funds/350894.md) | 2026-06-30 | $723.2k | 157,210 |  | Reduced −15,194 |
| [Informed Momentum Co LLC](/funds/1510989.md) | 2026-06-30 | $625.8k | 136,047 |  | Reduced −5,598 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $541.5k | 117,711 |  | Added +13,044 |
| [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $512.4k | 111,400 |  | Added +30,973 |
| [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $504.0k | 109,559 |  | Added +94,959 |
| [CORSAIR CAPITAL MANAGEMENT, L.P.](/funds/1276470.md) | 2026-06-30 | $460.0k | 100,000 |  | Unchanged |

## Recent filings

[All 192 filings](/companies/bof/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-22 | 17:23 ET | [8-K](/filings/0001493152-26-048132.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-048132 |
| 2026-09-02 | 16:05 ET | [8-K](/filings/0001493152-26-041232.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-041232 |
| 2026-08-31 | 16:05 ET | [8-K](/filings/0001493152-26-040819.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-040819 |
| 2026-08-28 | 16:05 ET | [8-K](/filings/0001493152-26-040578.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-040578 |
| 2026-08-13 | 16:05 ET | [8-K](/filings/0001493152-26-037745.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-037745 |
| 2026-08-13 | 16:00 ET | [10-Q](/filings/0001493152-26-037732.md) | Quarterly report, period 2026-06-30 | 0001493152-26-037732 |
| 2026-08-04 | 16:05 ET | [8-K](/filings/0001493152-26-035987.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-26-035987 |
| 2026-07-02 | 18:54 ET | [SCHEDULE 13D/A](/filings/0001099910-26-000228.md) | Ownership report, active investor, amended | 0001099910-26-000228 |
| 2026-07-01 | 09:00 ET | [8-K](/filings/0001493152-26-031446.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-26-031446 |
| 2026-06-04 | 16:03 ET | [SCHEDULE 13D/A](/filings/0001099910-26-000205.md) | Ownership report, active investor, amended | 0001099910-26-000205 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001493152-26-014040.md), filed Mar 31, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/e5cb566e-14b6-41a6-9122-9265a3016468)

## About the filer

- CIK: 1962481
- Tickers: BOF
- Exchange: Nasdaq
- SIC code: 2000 Food and Kindred Products
- State of incorporation: NV
- Filer category: <br>Emerging growth company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 26, 2026, 16:06 ET. No prices; not investment advice.
